<?xml version='1.0' encoding='utf-8'?>
<document id="29571134"><sentence text="Determination of oroxylin A and oroxylin A 7-O-d-glucuronide in HepG2 cell lysate and subcellular fractions with SPE-UPLC-MS/MS: Cellular pharmacokinetic study to indicate anti-cancer mechanisms."><entity charOffset="17-27" id="DDI-PubMed.29571134.s1.e0" text="oroxylin A" /><entity charOffset="32-60" id="DDI-PubMed.29571134.s1.e1" text="oroxylin A 7-O-d-glucuronide" /><pair ddi="false" e1="DDI-PubMed.29571134.s1.e0" e2="DDI-PubMed.29571134.s1.e0" /><pair ddi="false" e1="DDI-PubMed.29571134.s1.e0" e2="DDI-PubMed.29571134.s1.e1" /></sentence><sentence text="Targeting therapy of anti-cancer drugs has been gaining increasing attention" /><sentence text=" Cell pharmacokinetics have been used for in vitro disposition evaluation, as well as drug-drug interaction for anti-cancer drugs, revealing their fate after entering tumor" /><sentence text=" Flavonoid compound oroxylin A (OA) possesses strong anti-cancer effects especially on the liver and breast cancer"><entity charOffset="1-10" id="DDI-PubMed.29571134.s4.e0" text="Flavonoid" /><entity charOffset="20-30" id="DDI-PubMed.29571134.s4.e1" text="oroxylin A" /><pair ddi="false" e1="DDI-PubMed.29571134.s4.e0" e2="DDI-PubMed.29571134.s4.e0" /><pair ddi="false" e1="DDI-PubMed.29571134.s4.e0" e2="DDI-PubMed.29571134.s4.e1" /></sentence><sentence text=" However, despite the low bioavailability, the disposition of OA and its active metabolite in the target cancer cells remained unclear" /><sentence text=" In current study, a highly sensitive and selective solid phase extraction (SPE)-UPLC-MS/MS method was developed and validated to simultaneously quantify the concentrations of OA and its major active metabolite oroxylin A 7-O-d-glucuronide (OG) in HepG2 cell lysate and multiple subcellular organelle fractions"><entity charOffset="222-239" id="DDI-PubMed.29571134.s6.e0" text="7-O-d-glucuronide" /><entity charOffset="241-243" id="DDI-PubMed.29571134.s6.e1" text="OG" /><pair ddi="false" e1="DDI-PubMed.29571134.s6.e0" e2="DDI-PubMed.29571134.s6.e0" /><pair ddi="false" e1="DDI-PubMed.29571134.s6.e0" e2="DDI-PubMed.29571134.s6.e1" /></sentence><sentence text=" The proposed method appeared to be suitable for the analysis with desirable linearity(R2 &gt; 0" /><sentence text="99)" /><sentence text=" The relative standard deviations (RSDs) of intra- and inter-assay precision and accuracy were less than 9" /><sentence text="9% and -7" /><sentence text="7%, 8" /><sentence text="4% and 11% for OA and OG in cell lysate respectively"><entity charOffset="22-23" id="DDI-PubMed.29571134.s12.e0" text="OG" /></sentence><sentence text=" The intra- precision and accuracy was less than 9" /><sentence text="5% and -11" /><sentence text="3%, 9" /><sentence text="4% and 12" /><sentence text="3% for OA and OG in subcellular organelles respectively"><entity charOffset="14-15" id="DDI-PubMed.29571134.s17.e0" text="OG" /></sentence><sentence text=" The range of absolute recovery of this method in the cell lysate was from 73" /><sentence text="1% ± 1" /><sentence text="4% to 87" /><sentence text="9% ± 6" /><sentence text="7%" /><sentence text=" The RSDs of matrix effects of the quality control (QC) samples were below 15%" /><sentence text=" The uptake and distribution experiments demonstrated a time-dependent transport characteristic in HepG2 cell lines" /><sentence text=" Furthermore, both OA and OG were mainly distributed into nuclei after taken up by the tumor cells"><entity charOffset="26-27" id="DDI-PubMed.29571134.s25.e0" text="OG" /></sentence><sentence text=" In addition, OG was also distributed into mitochondria, which indicates another potential target of OG"><entity charOffset="14-15" id="DDI-PubMed.29571134.s26.e0" text="OG" /><entity charOffset="101-102" id="DDI-PubMed.29571134.s26.e1" text="OG" /><pair ddi="false" e1="DDI-PubMed.29571134.s26.e0" e2="DDI-PubMed.29571134.s26.e0" /><pair ddi="false" e1="DDI-PubMed.29571134.s26.e0" e2="DDI-PubMed.29571134.s26.e1" /></sentence><sentence text=" The present study, for the first time, reports the in vitro cell pharmacokinetics profiles of OA and OG in tumor cell lines in vitro"><entity charOffset="102-103" id="DDI-PubMed.29571134.s27.e0" text="OG" /></sentence><sentence text="" /></document>